ACKNOWLEDGMENTS
P.B thanks members of his laboratory for helpful discussions and
apologizes beforehand to the many colleagues whose work could not
be cited in this manuscript due to limited space.Funding:P.B is
supported by the Garfield Weston Foundation, the Academy of
Medical Sciences, the European Research Council, the Swedish
Research Council, the Knut and Alice Wallenberg Foundation, and
the Karolinska Institutet.Competing interests:P.B is a founder of
Cytodelics AB (Stockholm, Sweden), a board member of Kancera
AB (Stockholm, Sweden), and a scientific adviser to Pixelgen AB
(Stockholm, Sweden), Scailyte AG (Basel, Switzerland), and Oxford
Immune Algorithmics (Reading, UK). P.B. also has a funded research
collaboration with Johnson & Johnson.License information:
Copyright © 2022 the authors, some rights reserved; exclusivelicensee American Association for the Advancement of Science.
No claim to original US government works. https://www.science.org/
about/science-licenses-journal-article-reuse.Submitted 5 February 2022; accepted 26 April 2022
10.1126/science.abk2189Brodin,Science 376 , 945–950 (2022) 27 May 2022 6of6